Browsing by Author Cullinane, Carleen

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 11 of 11
Issue DateTitleAuthor(s)Citation
2015Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signalingDe Paoli-Iseppi, Ricardo; Gallagher, Stuart; Gowrishankar, Kavitha; Gunatilake, Dilini; Heinemann, Anja; Hersey, Peter; Madore, Jason; Strbenac, Dario; Tiffen, Jessamy; Wilmott, James; Yang, Jean Yee Hwa; Cullinane, Carleen; McArthur, Grant A.; Prinjha, Rab; Smithers, Nicholas; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Mathematics & Statistics; Central Clinical School: Centenary Institute; Central Clinical School: Surgery; Mathematics & StatisticsCombining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling, Oncotarget, vol.6, 25, 2015,pp 21507-21521
2014Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151Gallagher, Stuart; Gowrishankar, Kavitha; Gunatilake, Dilini; Hersey, Peter; Jin, Lei; Mijatov, Branka; Pupo, Gulietta; Rizos, Helen; Tiffen, Jessamy; Cullinane, Carleen; James, Wilmott; McArthur, Grant A.; Tummino, Peter J; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteControl of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151, Pigment Cell & Melanoma Research, vol.27, 6, 2014,pp 1126-1137
2012Docetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance testClarke, Stephen; Booth, R; Cullinane, Carleen; Francis, P A; Hatzimihalis, A; Michael, Michael; Milner, Alvin D.; O'Kane, C; Schlicht, S; Northern Clinical School: Kolling InstituteDocetaxel pharmacokinetics and its correlation with two in vivo probes for cytochrome P450 enzymes: the C(14)-erythromycin breath test and the antipyrine clearance test, Cancer Chemotherapy and Pharmacology, vol.69, 1, 2012,pp 125-135
2014The Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma CellsGallagher, Stuart; Gowrishankar, Kavitha; Gunatilake, Dilini; Hersey, Peter; Jin, Lei; Mijatov, Branka; Pupo, Gulietta; Rizos, Helen; Tiffen, Jessamy; Cullinane, Carleen; McArthur, Grant A.; Prinjha, Rab; Smithers, Nicholas; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Northern Clinical School: Kolling Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteThe Epigenetic Regulator I-BET151 Induces BIM Dependent Apoptosis and Cell Cycle Arrest OF Human Melanoma Cells, Journal of Investigative Dermatology, vol.134, 11, 2014,pp 1523-1747
2012LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal DoxorubicindeFazio, Anna; Harnett, Paul; Anglesio, Michael; Cowin, Prue; Cullinane, Carleen; et al, Various; Etemadmoghadam, Dariush; Fereday, Sian; Ftouni, Sarah; Galletta, Laura; George, Joshy; Loehrer, Elizabeth; Van Loo, Peter; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead)LRP1B Deletion in High-Grade Serous Ovarian Cancers Is Associated with Acquired Chemotherapy Resistance to Liposomal Doxorubicin, Cancer Research, vol.72, 16, 2012,pp 4060-4073
2002Preparation and cell growth inhibitory activity of [PtR2L2] (R=polyfluorophenyl, L2 = diene, cyclohexane-1,2-diamine (chxn) or cis-(dimethyl sulfoxide)2) and the X-ray crystal structure of [Pt(C6F5)2(cis-chxn)]Hambley, Trevor; Cullinane, Carleen; Deacon, Glen B; Drago, Penny R; Nelson, Keith T; Webster, Lorraine K; ChemistryPreparation and cell growth inhibitory activity of [PtR2L2] (R=polyfluorophenyl, L2 = diene, cyclohexane-1,2-diamine (chxn) or cis-(dimethyl sulfoxide)2) and the X-ray crystal structure of [Pt(C6F5)2(cis-chxn)], Journal of Inorganic Biochemistry, vol.N/A,(N/A),2002,pp 293-301
2012Structural and anticancer properties of hydrogen bonded diphenyl phosphate adducts of Pt(IV) complexes: The importance of pKa matchingBattle, Andrew; Chen, Catherine; Failes, Timothy; Hambley, Trevor; Cullinane, Carleen; Deacon, Glen B; Elliott, Robyn; Woods, Ross; Chemistry; Chemistry; Chemistry; ChemistryStructural and anticancer properties of hydrogen bonded diphenyl phosphate adducts of Pt(IV) complexes: The importance of pKa matching, Journal of Inorganic Biochemistry, vol.115, N/A, 2012,pp 220-225
2007Studies of a cobalt(III) complex of the MMP inhibitor marimastat: A potential hypoxia-activated prodrugDiakos, Connie; Failes, Timothy; Hambley, Trevor; Yamamoto, Natsuho; Cullinane, Carleen; Lyons, J. Guy; Chemistry; Chemistry; Chemistry; ChemistryStudies of a cobalt(III) complex of the MMP inhibitor marimastat: A potential hypoxia-activated prodrug, Chemistry: A European Journal, vol.13,(10),2007,pp 2974-2982
2006Studies of a Cobalt(III) Complex of the MMP Inhibitor Marimastat: A Potential Hypoxia-Activated Prodrug.Lyons, James (Guy); Cullinane, Carleen; Diakos, Connie I; Failes, T; Hambley, Trevor W; Yamamoto, Natsuho; Central Clinical School: MedicineStudies of a Cobalt(III) Complex of the MMP Inhibitor Marimastat: A Potential Hypoxia-Activated Prodrug., Chemistry: A European Journal, vol.DOI: 10.1002/chem.200601137,(N/A),2006,pp N/A-N/A
2012Systematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl]Battle, Andrew; Hambley, Trevor; Bond, Alan; Cullinane, Carleen; Deacon, Glen B; Fallon, Gary D; Gatehouse, Bryan M.; Guo, Si-Xuan; Kelly, Lance C.; Lawrenz, Eric T.; Mason, Dayna; Rainone, Silvina; Turland, Susan A.; Webster, Lorraine K; Chemistry; ChemistrySystematic differences in electrochemical reduction of the structurally characterized anti-cancer platinum(IV) complexes [Pt{((p-HC6F4)NCH2)2}-(pyridine)2Cl2], [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)2], and [Pt{((p-HC6F4)NCH2)2}(pyridine)2(OH)Cl], Journal of Inorganic Biochemistry, vol.115, 2012, 2012,pp 226-239
2015Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genesGallagher, Stuart; Gowrishankar, Kavitha; Gunatilake, Dilini; Heinemann, Anja; Hersey, Peter; Madore, Jason; Mann, Graham; Pupo, Gulietta; Strbenac, Dario; Tiffen, Jessamy; Yang, Jean Yee Hwa; Cullinane, Carleen; Dutton-Regester, Ken; Filli[, Fabian V.; Hayward, Nicholas; McArthur, Grant A.; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Northern Clinical School: Kolling Institute; Northern Clinical School: Kolling Institute; Northern Clinical School: Surgery; Central Clinical School: Melonoma & Skin Cancer Res. Inst.; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Mathematics & Statistics; Central Clinical School: Centenary Institute; Mathematics & StatisticsTargeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes, Oncotarget, vol.6, 29, 2015,pp 27023-27036